Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy. Jalali A, Rothwell E, Botkin JR, Anderson RA, et al. J Pediatr 2020 Jul 10. pii: S0022-3476(20)30876.

Read + Share

Amedeo Smart

Independent Medical Education

Jalali A, Rothwell E, Botkin JR, Anderson RA, et al. Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy. J Pediatr 2020 Jul 10. pii: S0022-3476(20)30876.
PMID: 32659229